NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Fervent logo
Fervent Pharmaceuticals of Greenville has finished a Phase 2A clinical trial of FP-101, its new therapy for treating symptoms of menopause including hot flashes and night sweats.
Blockchain infographic
Perhaps the best way to know where food comes from, and where it’s been since its origin, is by using a fast-evolving technology-based system called blockchain. It’s a concept that enables tagging and tracking everything from food to fiber and beyond. And it’s going to rock our world.
Target PharmaSolutions logo
Chapel Hill-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has formed a strategic partnership with Gilead Sciences to better understand two major liver disorders.
Cambrex logo
Cambrex Corp., a contract manufacturer of small-molecule therapeutics with a growing facility in High Point, has signed an agreement to acquire Avista Pharma Solutions, a contract development, manufacturing and testing organization (CDMO) in East Rutherford, N.J., for about $252 million.
Seqirus logo
Seqirus, already the world’s largest producer of cell-based influenza vaccines, is about to grow even larger due to strong global demand for its quadrivalent flu vaccine.
Ribometrix logo
Durham-based Ribometrix, a developer of small-molecule therapeutics that target ribonucleic acid (RNA), has raised $30 million in Series A financing.​​​​​​​
Pairwise logo
Pairwise, a gene editing and plant technology start-up, is establishing its headquarters in leased space on the Golden Belt Campus in the heart of downtown Durham.
NCATS logo
The NIH's National Center for Advancing Translational Sciences has announced new SBIR and STTR funding opportunities for entrepreneurs aiming to commercialize innovations.
Invest in Cures Forum LaunchBio
North Carolina’s entrepreneurial companies had an opportunity to learn more about alternative funding sources through the venture arms of disease foundations at "Invest in Cures," a Larger Than Life Science event series forum.
Pinnacle Hill logo
Deerfield Management, an investment management, information and philanthropy firm, has given the University of North Carolina at Chapel Hill an injection of up to $65 million to spur drug discovery and development.
BioAgilytix Durham Headquarters
Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company.
Stryker logo
Fortune 500 medical technology firm acquires Durham-based company and keeps manufacturing of biosurgical sealant device in North Carolina.
Symberix logo
The challenge of developing new drugs to treat serious lower gastrointestinal disorders just got easier to digest for Symberix, a Durham biopharmaceutical company.
LabCorp logo
The road to better health is only a simple blood test away, thanks to a new consumer wellness package offered by Burlington-based global life sciences company LabCorp.
AAD's on-farm diagnostic system
Advanced Animal Diagnostics (AAD) of Morrisville has entered into a license and commercialization agreement with Zoetis, the world’s largest animal-health company, to bring AAD’s mastitis-detection technology to dairy producers and veterinarians outside of the United States.